Astroglial modulation of synaptic function in the non-demyelinated cerebellar cortex is dependent on MyD88 signaling in a model of toxic demyelination

Melanie Lohrberg, Lena Sünke Mortensen, Carolina Thomas, Franziska Fries, Franziska van der Meer, Alexander Götz, Carolin Landt, Hong Jun Rhee, JeongSeop Rhee, David Gómez-Varela, Manuela Schmidt, Wiebke Möbius, Torben Ruhwedel, Luis A Pardo, Linus Remling, Nadine Kramann, Claudia Wrzos, Erik Bahn, Christine Stadelmann (Korresp. Autor*in), Alonso Barrantes-Freer (Korresp. Autor*in)

Veröffentlichungen: Beitrag in FachzeitschriftArtikelPeer Reviewed

Abstract

Progressive neurological decline in multiple sclerosis is associated with axonal loss and synaptic dysfunction in the non-demyelinated normal appearing gray matter (NAGM) and prominently in the cerebellum. In contrast to early disease stages, where synaptic and neuro-axonal pathology correlates with the extent of T cell infiltration, a prominent role of the innate immune system has been proposed for progressive MS. However, the specific contribution of microglia and astrocytes to synaptic cerebellar pathology in the NAGM- independent of an adaptive T cell response - remains largely unexplored. In the present study, we quantified synaptic changes in the cerebellar NAGM distant from demyelinated lesions in a mouse model of toxic demyelination. Proteomic analysis of the cerebellar cortex revealed differential regulation of synaptic and glutamate transport proteins in the absence of evident structural synaptic pathology or local gray matter demyelination. At the functional level, synaptic changes manifested as a reduction in frequency-dependent facilitation at the parallel fiber- Purkinje cell synapse. Further, deficiency of MyD88, an adaptor protein of the innate immune response, associated with a functional recovery in facilitation, reduced changes in the differential expression of synaptic and glutamate transport proteins, and reduced transcription levels of inflammatory cytokines. Nevertheless, the characteristics of demyelinating lesions and their associated cellular response were similar to wild type animals. Our work brings forward an experimental paradigm mimicking the diffuse synaptic pathology independent of demyelination in late stage MS and highlights the complex regulation of synaptic pathology in the cerebellar NAGM. Moreover, our findings suggest a role of astrocytes, in particular Bergmann glia, as key cellular determinants of cerebellar synaptic dysfunction.

OriginalspracheEnglisch
Aufsatznummer47
Seitenumfang17
FachzeitschriftJournal of Neuroinflammation
Jahrgang22
Ausgabenummer1
DOIs
PublikationsstatusVeröffentlicht - 23 Feb. 2025

Fördermittel

This project was supported by the Deutsche Forschungsgemeinschaft (DFG) transregional collaborative research center (CRC) TRR 274/1 and TRR274/2, Project ID 408885537 B01, \u201CCheckpoints of CNS recovery\u201D (CS), STA 1389/5\u2009\u2212\u20091, the DFG under Germany\u2019s Excellence Strategy (EXC 2067/1- 390729940), the Gemeinn\u00FCtzige Hertie Foundation, the Deutsche Multiple Sklerose Gesellschaft (DMSG), and the National MS Society (USA), to CS. CT was supported by the clinician scientist program of the Cluster of Excellence \u201EMultiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells\u201C (MBExC) and is currently supported by the Bundesministerium f\u00FCr Bildung und Forschung (BMBF) Project ID 01EJ2203C.

ÖFOS 2012

  • 301405 Neuropathologie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Astroglial modulation of synaptic function in the non-demyelinated cerebellar cortex is dependent on MyD88 signaling in a model of toxic demyelination“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitationsweisen